Index S&P 500
P/E 10.80
EPS (ttm) 5.77
Insider Own 1.09%
Shs Outstand 510.08M
Perf Week 0.68%
Market Cap 31.43B
Forward P/E 8.62
EPS next Y 7.23
Insider Trans 1.01%
Shs Float 499.34M
Perf Month 5.21%
Income 3.07B
PEG 1.01
EPS next Q 0.49
Inst Own 98.47%
Short Float 1.61%
Perf Quarter -10.17%
Sales 161.73B
P/S 0.19
EPS this Y 2.23%
Inst Trans -5.34%
Short Ratio 1.27
Perf Half Y -5.24%
Book/sh 53.53
P/B 1.16
EPS next Y 5.81%
ROA 3.68%
Short Interest 8.04M
Perf Year -20.19%
Cash/sh -
P/C -
EPS next 5Y 10.68%
ROE 11.66%
52W Range 55.03 - 81.42
Perf YTD 2.76%
Dividend Est. -
P/FCF 128.28
EPS past 5Y 17.00%
ROI 6.85%
52W High -23.54%
Beta 0.45
Dividend TTM -
Quick Ratio -
Sales past 5Y 20.88%
Gross Margin -
52W Low 13.12%
ATR (14) 1.72
Dividend Ex-Date -
Current Ratio 1.10
EPS Y/Y TTM 29.54%
Oper. Margin 1.88%
RSI (14) 54.43
Volatility 2.36% 2.65%
Employees 76000
Debt/Eq 0.64
Sales Y/Y TTM 7.75%
Profit Margin 1.90%
Recom 2.00
Target Price 78.16
Option/Short Yes / Yes
LT Debt/Eq 0.64
EPS Q/Q 57.17%
Payout 0.00%
Rel Volume 0.69
Prev Close 62.87
Sales Surprise 10.79%
EPS Surprise 19.58%
Sales Q/Q 10.46%
Earnings Feb 04 BMO
Avg Volume 6.34M
Price 62.25
SMA20 1.22%
SMA50 3.34%
SMA200 -9.80%
Trades
Volume 4,387,651
Change -0.99%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-17-24 Resumed
JP Morgan
Overweight
$80 → $75
Dec-13-24 Upgrade
UBS
Neutral → Buy
$79 → $80
Dec-10-24 Downgrade
Jefferies
Hold → Underperform
$68 → $52
Jul-24-24 Downgrade
Jefferies
Buy → Hold
$83 → $69
May-30-24 Initiated
Robert W. Baird
Neutral
$83
Mar-21-24 Downgrade
Stephens
Overweight → Equal-Weight
$92 → $85
Mar-06-24 Initiated
Barclays
Overweight
$101
Jan-02-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$82 → $90
Sep-05-23 Upgrade
BofA Securities
Underperform → Neutral
$79 → $72
Aug-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$94 → $73
Jul-12-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-20-23 Initiated
UBS
Neutral
$72
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$80
Mar-08-23 Downgrade
Deutsche Bank
Buy → Hold
$94 → $79
Feb-23-23 Downgrade
JP Morgan
Overweight → Neutral
$94 → $90
Dec-13-22 Downgrade
BofA Securities
Neutral → Underperform
$100 → $85
Sep-30-22 Initiated
Argus
Buy
$90
Aug-26-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$103 → $99
Jul-28-22 Resumed
Barclays
Overweight
$107
Jul-14-22 Upgrade
Jefferies
Hold → Buy
$82 → $115
Show Previous Ratings
Jan-15-25 09:37AM
09:00AM
Jan-14-25 12:00PM
07:41AM
Jan-13-25 10:43AM
09:00AM
Loading…
Jan-09-25 09:00AM
06:34AM
Jan-08-25 01:35PM
Jan-07-25 09:00AM
Dec-28-24 05:04PM
Dec-18-24 07:54PM
04:57PM
Dec-16-24 07:00AM
Dec-13-24 05:38AM
Dec-12-24 04:11PM
(The Wall Street Journal)
03:33PM
Loading…
03:33PM
12:41PM
06:00AM
05:30AM
(The Wall Street Journal)
Dec-10-24 09:36PM
(The Wall Street Journal)
10:22AM
Dec-06-24 03:47AM
Dec-05-24 09:57PM
(The Wall Street Journal)
07:01PM
Dec-04-24 09:00AM
04:00AM
Dec-03-24 09:00AM
Dec-02-24 02:45PM
Nov-27-24 03:19PM
Nov-26-24 07:27AM
05:00AM
Loading…
05:00AM
(The Wall Street Journal)
05:00AM
(The Wall Street Journal)
Nov-21-24 08:33AM
Nov-20-24 12:10PM
(The Wall Street Journal)
Nov-19-24 06:15AM
Nov-15-24 10:45AM
Nov-14-24 05:57AM
Nov-13-24 05:49AM
Nov-07-24 07:00AM
Nov-06-24 11:17AM
(The Wall Street Journal)
09:43AM
Nov-04-24 01:16PM
Nov-01-24 05:51PM
Oct-30-24 06:14PM
08:30AM
Oct-29-24 11:05AM
11:00AM
07:00AM
Oct-28-24 05:13PM
05:07PM
Oct-26-24 06:25AM
03:05AM
01:06AM
12:38AM
(Thomson Reuters StreetEvents)
Oct-25-24 04:02PM
01:30PM
12:55PM
11:47AM
11:12AM
10:26AM
(The Wall Street Journal)
10:21AM
09:46AM
09:30AM
08:04AM
07:29AM
07:10AM
06:15AM
06:09AM
(Associated Press Finance)
06:00AM
Oct-24-24 02:24PM
(The Wall Street Journal)
Oct-23-24 04:32AM
Oct-22-24 09:15AM
Oct-21-24 06:58PM
Oct-19-24 07:00AM
(The Wall Street Journal)
Oct-18-24 10:00AM
Oct-17-24 05:10PM
03:04PM
(The Wall Street Journal)
08:00AM
Oct-15-24 10:07AM
07:00AM
Oct-14-24 02:56PM
Oct-12-24 07:41AM
Oct-11-24 05:30AM
(The Wall Street Journal)
Oct-09-24 06:29AM
Oct-08-24 08:30AM
Oct-07-24 08:00AM
Oct-02-24 08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Greco Thomas Director Dec 18 '24 Buy 59.75 17,000 1,015,750 19,309 Dec 19 05:39 PM Dallas H James Director Dec 16 '24 Buy 59.01 1,693 99,904 1,693 Dec 17 07:34 PM BLUME JESSICA L. Director Dec 16 '24 Buy 59.48 250 14,870 250 Dec 17 07:33 PM COUGHLIN CHRISTOPHER J Director Dec 16 '24 Buy 59.44 10,000 594,400 36,358 Dec 17 07:33 PM Samuels Theodore R. II Director Dec 13 '24 Buy 58.86 5,000 294,300 23,000 Dec 17 07:33 PM Asher Andrew Lynn Chief Financial Officer Nov 13 '24 Buy 58.14 17,200 1,000,008 486,847 Nov 13 06:07 PM LONDON SARAH Chief Executive Officer Nov 08 '24 Buy 60.80 4,117 250,314 667,229 Nov 08 06:15 PM COUGHLIN CHRISTOPHER J Director May 14 '24 Sale 76.75 878 67,382 0 May 24 05:28 PM FASOLA KENNETH J President May 13 '24 Sale 77.62 8,000 620,960 300,357 May 15 06:10 PM Robinson Lori Jean Director Feb 13 '24 Option Exercise 54.65 10,000 546,500 21,455 Feb 15 06:31 PM Robinson Lori Jean Director Feb 13 '24 Sale 77.41 10,000 774,100 11,455 Feb 15 06:31 PM FASOLA KENNETH J President Feb 07 '24 Sale 75.07 12,000 900,817 235,365 Feb 08 07:38 PM
Index S&P 500
P/E -
EPS (ttm) -3.60
Insider Own 0.08%
Shs Outstand 2.03B
Perf Week 0.82%
Market Cap 114.17B
Forward P/E 8.06
EPS next Y 6.98
Insider Trans 0.07%
Shs Float 2.03B
Perf Month 0.75%
Income -7258.00M
PEG -
EPS next Q 1.47
Inst Own 77.71%
Short Float 1.23%
Perf Quarter 5.47%
Sales 47.44B
P/S 2.41
EPS this Y -87.99%
Inst Trans 0.28%
Short Ratio 2.36
Perf Half Y 32.79%
Book/sh 8.45
P/B 6.66
EPS next Y 674.08%
ROA -7.85%
Short Interest 24.93M
Perf Year 12.63%
Cash/sh 3.99
P/C 14.10
EPS next 5Y -5.00%
ROE -31.46%
52W Range 39.35 - 61.08
Perf YTD -0.48%
Dividend Est. 2.39 (4.25%)
P/FCF 8.27
EPS past 5Y 5.14%
ROI -10.78%
52W High -7.84%
Beta 0.45
Dividend TTM 2.42 (4.30%)
Quick Ratio 1.09
Sales past 5Y 17.18%
Gross Margin 55.87%
52W Low 43.05%
ATR (14) 1.11
Dividend Ex-Date Jan 03, 2025
Current Ratio 1.24
EPS Y/Y TTM -190.62%
Oper. Margin 17.62%
RSI (14) 47.19
Volatility 1.80% 1.86%
Employees 34100
Debt/Eq 3.00
Sales Y/Y TTM 5.56%
Profit Margin -15.30%
Recom 2.57
Target Price 60.37
Option/Short Yes / Yes
LT Debt/Eq 2.93
EPS Q/Q -36.16%
Payout 59.82%
Rel Volume 1.03
Prev Close 56.38
Sales Surprise 5.57%
EPS Surprise 20.47%
Sales Q/Q 8.44%
Earnings Feb 06 BMO
Avg Volume 10.58M
Price 56.29
SMA20 -0.69%
SMA50 -1.80%
SMA200 13.59%
Trades
Volume 10,908,444
Change -0.16%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-16-24 Upgrade
Jefferies
Hold → Buy
$70
Dec-10-24 Resumed
BofA Securities
Neutral
$63
Nov-15-24 Initiated
Wolfe Research
Peer Perform
Nov-13-24 Upgrade
Daiwa Securities
Neutral → Outperform
Nov-12-24 Upgrade
Leerink Partners
Market Perform → Outperform
$73
Oct-25-24 Downgrade
Citigroup
Buy → Neutral
$75 → $55
Oct-17-24 Initiated
Bernstein
Mkt Perform
$56
Jul-29-24 Downgrade
Barclays
Overweight → Equal Weight
$41
Mar-11-24 Downgrade
Societe Generale
Buy → Hold
Feb-06-24 Downgrade
Redburn Atlantic
Buy → Neutral
$77 → $54
Jan-03-24 Downgrade
BofA Securities
Buy → Neutral
$68 → $60
Nov-15-23 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$68 → $55
Nov-09-23 Initiated
Deutsche Bank
Hold
$55
Nov-02-23 Downgrade
Daiwa Securities
Outperform → Neutral
$68 → $54
Oct-27-23 Upgrade
HSBC Securities
Reduce → Hold
$55 → $53
Oct-27-23 Downgrade
William Blair
Outperform → Mkt Perform
Oct-27-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$60
Oct-20-23 Resumed
UBS
Neutral
$70 → $60
Jul-14-23 Initiated
HSBC Securities
Reduce
$56
Jul-10-23 Initiated
SVB Securities
Market Perform
$66
Show Previous Ratings
Jan-17-25 11:10AM
(The Wall Street Journal)
09:46AM
Jan-13-25 03:13PM
(The Wall Street Journal)
07:00AM
Jan-10-25 12:50PM
08:30AM
Loading…
08:30AM
Jan-06-25 09:00AM
Jan-03-25 06:59AM
Dec-31-24 01:14PM
Dec-30-24 02:14PM
Dec-27-24 05:37PM
Dec-23-24 06:59AM
06:45AM
Dec-19-24 02:28PM
(Investor's Business Daily)
06:59AM
01:48AM
Loading…
01:48AM
Dec-18-24 09:00AM
08:45AM
Dec-17-24 06:30AM
Dec-11-24 04:17PM
Dec-09-24 05:45PM
Dec-07-24 05:30AM
(The Wall Street Journal)
Dec-03-24 08:00AM
Dec-02-24 07:44AM
Nov-26-24 06:59AM
Nov-22-24 04:09PM
(Investor's Business Daily)
11:30AM
(Investor's Business Daily)
Nov-19-24 06:59AM
Nov-18-24 07:30AM
12:41AM
07:22PM
Loading…
Nov-15-24 07:22PM
08:23AM
06:59AM
Nov-13-24 04:07PM
(Investor's Business Daily)
Nov-12-24 04:05PM
07:00AM
(The Wall Street Journal)
Nov-11-24 07:00PM
(Morningstar Research) +10.49%
04:32PM
04:04PM
(Investor's Business Daily)
03:45PM
10:12AM
(Investor's Business Daily)
09:39AM
(The Wall Street Journal)
06:59AM
Nov-08-24 09:34AM
Nov-05-24 05:00PM
Nov-01-24 03:07PM
(Investor's Business Daily)
Oct-31-24 04:16PM
04:12PM
(Investor's Business Daily)
02:43PM
10:03AM
07:12AM
(Investor's Business Daily)
06:59AM
Oct-29-24 11:17AM
Oct-28-24 06:59AM
Oct-26-24 07:00AM
(The Wall Street Journal)
Oct-16-24 04:21PM
(Investor's Business Daily)
Oct-15-24 06:09PM
(Investor's Business Daily)
Oct-14-24 09:59PM
Oct-07-24 05:30AM
(The Wall Street Journal)
Oct-03-24 05:35PM
01:11PM
(Investor's Business Daily)
Sep-30-24 07:00AM
Sep-27-24 07:38PM
04:18PM
(The Wall Street Journal)
02:17PM
(The Wall Street Journal)
11:58AM
11:06AM
11:00AM
09:44AM
(The Wall Street Journal)
09:36AM
(The Wall Street Journal)
06:59AM
(The Wall Street Journal)
05:59AM
(The Wall Street Journal)
Sep-26-24 09:05PM
07:20PM
(The Wall Street Journal)
Sep-25-24 08:29PM
Sep-18-24 06:59AM
Sep-16-24 05:25AM
Sep-15-24 08:55AM
Sep-12-24 06:59AM
Sep-10-24 05:45PM
Sep-09-24 06:59AM
Sep-08-24 02:30AM
Sep-06-24 07:00AM
Sep-01-24 03:33AM
Aug-28-24 06:19PM
Aug-27-24 06:59AM
Aug-26-24 06:59AM
Aug-21-24 06:59AM
Aug-19-24 06:59AM
Aug-16-24 07:30AM
(The Wall Street Journal)
Aug-15-24 05:30PM
03:48PM
12:34PM
10:49AM
07:49AM
Aug-08-24 06:30AM
(The Wall Street Journal)
Jul-29-24 06:30AM
(The Wall Street Journal)
Jul-27-24 11:31AM
Jul-26-24 07:06PM
(Morningstar Research) +11.44%
01:26PM
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Holzer Phil M SVP and Controller Nov 04 '24 Sale 55.62 700 38,930 11,760 Nov 05 05:53 PM BOERNER CHRISTOPHER S. Chief Executive Officer Nov 01 '24 Option Exercise 0.00 2,964 0 104,169 Nov 05 05:42 PM Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Nov 01 '24 Buy 54.67 1,830 100,055 62,109 Nov 05 05:41 PM Holzer Phil M Officer Nov 04 '24 Proposed Sale 55.62 700 38,930 Nov 04 11:20 AM Gallman Cari EVP, Corporate Affairs Oct 02 '24 Option Exercise 0.00 4,558 0 6,667 Oct 03 06:33 PM Gallman Cari EVP, Corporate Affairs Aug 01 '24 Option Exercise 0.00 1,061 0 2,493 Aug 05 06:01 PM Shanahan Karin EVP, Glob. Prod. Dev. & Supply Apr 01 '24 Option Exercise 0.00 3,306 0 6,532 Apr 02 06:45 PM Lenkowsky Adam EVP, Chief Commercial Officer Mar 10 '24 Option Exercise 0.00 15,016 0 13,859 Mar 12 09:54 PM LEUNG SANDRA EVP, General Counsel Mar 10 '24 Option Exercise 0.00 46,784 0 371,312 Mar 12 09:43 PM Plenge Robert M EVP, Chief Research Officer Mar 10 '24 Option Exercise 0.00 9,143 0 15,182 Mar 12 09:21 PM Poole Ahn Amanda EVP, Chief Human Resources Mar 10 '24 Option Exercise 0.00 5,458 0 4,841 Mar 12 09:11 PM Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Mar 10 '24 Option Exercise 0.00 38,388 0 80,256 Mar 12 08:40 PM Holzer Phil M SVP and Controller Mar 10 '24 Option Exercise 0.00 5,520 0 14,916 Mar 12 08:31 PM Hoch Lynelle President, Cell Therapy Org. Mar 10 '24 Option Exercise 0.00 4,351 0 3,781 Mar 12 08:01 PM Gallman Cari EVP, Corporate Affairs Mar 10 '24 Option Exercise 0.00 2,761 0 2,655 Mar 12 08:00 PM BOERNER CHRISTOPHER S. Chief Executive Officer Mar 10 '24 Option Exercise 0.00 54,638 0 129,769 Mar 12 07:58 PM Elkins David V EVP, Chief Financial Officer Mar 10 '24 Option Exercise 0.00 64,326 0 225,111 Mar 12 05:43 PM Caforio Giovanni Executive Chair of the Board Mar 10 '24 Option Exercise 0.00 190,130 0 529,662 Mar 12 05:42 PM Meyers Gregory Scott EVP, Chief Digital & Tech Off. Feb 01 '24 Option Exercise 0.00 2,543 0 6,040 Feb 05 07:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite